<DOC>
	<DOCNO>NCT00323986</DOCNO>
	<brief_summary>Aims study - evaluate rate enteric gram negative bacteria colonization tracheotomised COPD patient - evaluate effect azithromycin long-term treatment Pseudomonas aeruginosa colonization colony count , reduction number exacerbations/hospitalisations , antibiotic course steroid use . - evaluate Quality Life patient treat treated azithromycin , use validate Italian version St George questionnaire - evaluate rate chronic colonization atypical pathogen - evaluate safety tolerability long-term treatment azithromycin , include survey possible bacterial antibiotic resistance pattern variation</brief_summary>
	<brief_title>Azithromycin Treatment Patients With Chronic Obstructive Pulmonary Disease ( COPD ) Tracheostomy</brief_title>
	<detailed_description>Methods . Study Design Prospective , randomise , multicentre study . Centers - Dott . E. Guffanti , IRCCS INRCA Casatenovo , Varese Italy - Prof. F. Blasi , Università degli Studi di Milano , IRCCS Ospedale Maggiore Milan Italy - Dott , M. Confalonieri , Ospedale Trieste , Italy Patients We plan enrol 30 patient : Inclusion criterion - Age &gt; 45 year - Tracheotomy - History COPD demonstrate pulmonary function test - Informed Consent Exclusion criterion - Allergy macrolides - Life expectancy &lt; 1 year Exhaled breath condensate ( EBC ) The breath condensate sample collect use specially design condense chamber ( Ecoscreen ; Jaeger , Hoechberg , Germany ) . The exhaled air enter left chamber though one-way inlet outlet valve , thus keep chamber close . The subject wear noseclips breathe tidally mouthpiece connect condenser ten minute . Approximately 1 ml sample material transfer 2-ml plastic tube store -70°C . Interleukin-6 assay Interleukin-6 concentration breath condensate measure use specific enzyme immunoassay kit ( EIA ) ( Cayman Chemical , Ann Arbor , USA ) . The assay directly validate mean gas chromatography/mass spectrometry order obtain high correlation ( r=0.95 ) know amount IL-6 concentration measure EIA . The detection limit assay 1.5 pg/ml two-hour development period . TNF alfa TNF-alfa serum level measure enzyme immunoassay ( Cayman Chemical , Ann Arbor , USA ) Microbiology Quantitative culture tracheal aspirate perform steady state , every 3 month exacerbation . Molecular biology technique Streptococcus pneumoniae , Haemophilus influenzae , Moraxella catarrhalis , Pseudomonas aeruginosa , Chlamydia pneumoniae Mycoplasma pneumoniae identification also apply specimen . Timetable Enrolment : January 2004 December 2005 Visits : Every 3 month exacerbation/hospitalization visit perform . Every month phone call perform . Follow-up : 12 month . End study : July 2006 Visit 1 . Visit 1 . A complete history record . Inclusion exclusion criterion check . Informed consent collect QoL questionnaire complete . Tracheal aspirate perform divide two aliquot : one local microbiology lab quantitative culture , one central lab bacterial detection PCR ( store –80°C ) . Exhaled breath sample obtain . 2 . Follow-up visit . Every 3 month patient recall center Visit 1 procedure repeat . Number exacerbations/hospitalisation record QoL questionnaire complete . 3 . Exacerbation/hospitalisation visit . In presence symptom deterioration patient instruct contact center visit . All Visit 1 procedure repeat . 4 . End study visit . At end 12 month follow-up Visit 1 procedure repeat . Number exacerbations/hospitalisation record QoL questionnaire complete . Treatment Patients randomise receive usual care usual care + Azithromycin 500 mg o.d . three day-a-week ( Monday , Tuesday , Wednesday ) 6 month . Outcome measure - reduction inflammatory cytokine EBC - reduction colony counts/eradication bacteria bronchial aspirate - reduction number exacerbations/hospitalisations - reduction steroid antibiotic use - Quality life</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Age &gt; 45 year Tracheotomy History COPD demonstrate pulmonary function test Informed Consent Allergy macrolides Life expectancy &lt; 1 year</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2006</verification_date>
	<keyword>COPD</keyword>
	<keyword>tracheotomy</keyword>
	<keyword>azithromycin</keyword>
	<keyword>exacerbation</keyword>
	<keyword>hospitalisation</keyword>
	<keyword>exhale breath condensate</keyword>
</DOC>